Immune response, inflammation, and the clinical spectrum of COVID-19
LF García - Frontiers in immunology, 2020 - frontiersin.org
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly
extended to become a global sanitary and economic emergency. Its etiological agent is the …
extended to become a global sanitary and economic emergency. Its etiological agent is the …
[HTML][HTML] Immunology of COVID-19: current state of the science
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …
The BLT Humanized Mouse Model as a Tool for Studying Human Gamma Delta T Cell-HIV Interactions In Vivo
Gamma-delta (γδ) T cells recognize antigens in a major histocompatibility complex (MHC)
independent and have cytotoxic capability. Human immunodeficiency virus (HIV) infection …
independent and have cytotoxic capability. Human immunodeficiency virus (HIV) infection …
Imperfect storm: is interleukin-33 the Achilles heel of COVID-19?
The unique cytokine signature of COVID-19 might provide clues to disease mechanisms and
possible future therapies. Here, we propose a pathogenic model in which the alarmin …
possible future therapies. Here, we propose a pathogenic model in which the alarmin …
Immune responses in mildly versus critically ill COVID-19 patients
H Nasrollahi, AG Talepoor, Z Saleh… - Frontiers in …, 2023 - frontiersin.org
The current coronavirus pandemic (COVID-19), caused by SARS-CoV-2, has had
devastating effects on the global health and economic system. The cellular and molecular …
devastating effects on the global health and economic system. The cellular and molecular …
Adaptive immune cells are necessary for SARS-CoV-2–induced pathology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the ongoing
global pandemic associated with morbidity and mortality in humans. Although disease …
global pandemic associated with morbidity and mortality in humans. Although disease …
Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity
AT Ambikan, H Yang, S Krishnan, SS Akusjärvi… - Cell systems, 2022 - cell.com
The clinical outcome and disease severity in coronavirus disease 2019 (COVID-19) are
heterogeneous, and the progression or fatality of the disease cannot be explained by a …
heterogeneous, and the progression or fatality of the disease cannot be explained by a …
COVID-19: immunology, immunopathogenesis and potential therapies
Abstract The Coronavirus Disease-2019 (COVID-19) imposed public health emergency and
affected millions of people around the globe. As of January 2021, 100 million confirmed …
affected millions of people around the globe. As of January 2021, 100 million confirmed …
A machine-generated view of the role of blood glucose levels in the severity of COVID-19
E Logette, C Lorin, C Favreau, E Oshurko… - Frontiers in Public …, 2021 - frontiersin.org
SARS-CoV-2 started spreading toward the end of 2019 causing COVID-19, a disease that
reached pandemic proportions among the human population within months. The reasons for …
reached pandemic proportions among the human population within months. The reasons for …
Cellular and humoral immune responses in covid-19 and immunotherapeutic approaches
A Hasan, E Al-Ozairi, Z Al-Baqsumi… - ImmunoTargets and …, 2021 - Taylor & Francis
Abstract Coronavirus disease 2019 (Covid-19), caused by the novel coronavirus severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can range in severity from …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can range in severity from …